A61K38/47 - page 6 - CPC Classification Index

#1501

20140187502

2014-07-03

Peptide linkers for polypeptide compositions and methods for using same

#1502

20140186433

2014-07-03

Cosmetic treatment system and methods

#1503

20140178330

2014-06-26

PH20 polypeptide variants, formulations and uses thereof

#1504

20140171491

2014-06-19

Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

#1505

20140170212

2014-06-19

Stable digestive enzyme compositions

#1506

20140170115

2014-06-19

Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy

#1507

20140161896

2014-06-12

PARTICLES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#1508

20140161788

2014-06-12

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#1509

20140161787

2014-06-12

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

#1510

20140147500

2014-05-29

Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems

#1511

20140140977

2014-05-22

Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders

#1512

20140135682

2014-05-15

Method for control of post-prandial glucose

#1513

20140134213

2014-05-15

Treatment of microbial infections

#1514

20140134150

2014-05-15

TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES

#1515

20140134149

2014-05-15

Enzymes for inhibiting growth of biofilms and degrading same

#1516

20140127307

2014-05-08

MICROPELLET COMPOSITIONS COMPRISING PANCREATIN CONTAINING DIGESTIVE ENZYME MIXTURE

#1517

20140127227

2014-05-08

Protein formulations containing amino acids

#1518

20140127184

2014-05-08

Methods of treatment of schizophrenia

#1519

20140120074

2014-05-01

ANTIMICROBIAL AGENTS

#1520

20140112907

2014-04-24

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#1521

20140105880

2014-04-17

USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES

#1522

20140105824

2014-04-17

Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

#1523

20140099380

2014-04-10

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

#1524

20140099296

2014-04-10

TOPICALLY OR ORALLY APPLIED ALOE, DISTILLED WATER, SODIUM CHLORIDE, AND LYSOZYME MIXTURE AND METHOD OF PRODUCING THE MIXTURE

#1525

20140086896

2014-03-27

Compositions for preventing and/or treating lysosomal storage disorders

#1526

20140079727

2014-03-20

NEW ENDOLYSIN PLYP40

#1527

20140079671

2014-03-20

Antibacterial phage, phage peptides and methods of use thereof

#1528

20140072549

2014-03-13

bacteriophage lysins for detection and treatment of gram positive bacteria

#1529

20140065128

2014-03-06

Treatment for IgE-mediated disease

#1530

20140065066

2014-03-06

Method of imaging osteoarthritis using a folate conjugate

#1531

20140056885

2014-02-27

Subcutaneously administered anti-IL-6 receptor antibody

#1532

20140056884

2014-02-27

Subcutaneously administered anti-IL-6 receptor antibody for treatment of systemic sclerosis

#1533

20140050715

2014-02-20

PROTEIN HYDROLYSATES AS AGENTS FOR OVERCOMING ADDICTION

#1534

20140050714

2014-02-20

Use of HSP70 as a regulator of enzymatic activity

#1535

20140050666

2014-02-20

Scavenger receptor uptake for fabry disease enzyme replacement therapy

#1536

20140044699

2014-02-13

Polynucleotides encoding proteins having acquired α-galactosidase activity

#1537

20140044694

2014-02-13

Pharmaceutical composition for treating lysosomal storage disease

#1538

20140043588

2014-02-13

Contact lens use in the treatment of an ophthalmologic condition

#1539

20140037613

2014-02-06

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#1540

20140037612

2014-02-06

SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A

#1541

20140037611

2014-02-06

Treatment of Pompe's Disease

#1542

20140030333

2014-01-30

Method of treating toxemia

#1543

20140023633

2014-01-23

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#1544

20140017224

2014-01-16

NOVEL ENDOLYSIN

#1545

20140017220

2014-01-16

Treatment of ophthalmic conditions

#1546

20140012230

2014-01-09

Method for treatment of cardiac disorders

#1547

20140010788

2014-01-09

Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy

#1548

20130344145

2013-12-26

ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF

#1549

20130344048

2013-12-26

Method of reducing insulin resistance by administering a Hyaluronan-degrading enzyme

#1550

20130336941

2013-12-19

LONG LASTING ABSORPTION OF FLAVONOIDS

#1551

20130330315

2013-12-12

Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug

#1552

20130323226

2013-12-05

Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

#1553

20130323223

2013-12-05

Methods of treating Celiac disease

#1554

20130309220

2013-11-21

COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS

#1555

20130302400

2013-11-14

Combination therapy with an anti-hyaluronan agent and therapeutic agent

#1556

20130302306

2013-11-14

Bacteriophage lysin and antibiotic combinations against gram positive bacteria

#1557

20130302275

2013-11-14

PH20 polypeptide variants, formulations and uses thereof

#1558

20130296232

2013-11-07

Peptides containing tryptophan

#1559

20130295077

2013-11-07

Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase

#1560

20130295071

2013-11-07

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASE

#1561

20130295069

2013-11-07

Metallo-lactoferrin-coenzyme compositions and methods for weight management

#1562

20130295066

2013-11-07

Metallo-lactoferrin-coenzyme compositions for detoxification support

#1563

20130295065

2013-11-07

Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

#1564

20130280332

2013-10-24

Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients

#1565

20130273026

2013-10-17

COMPOSITION AND METHOD FOR MODULATING INFLAMMATORY MOLECULES WITH AMYLASE

#1566

20130266555

2013-10-10

THERAPEUTIC AGENT FOR DISC HERNIATION

#1567

20130259852

2013-10-03

Lysozyme gel formulations

#1568

20130259848

2013-10-03

Enzyme combinations to reduce brain tissue swelling

#1569

20130251786

2013-09-26

Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia

#1570

20130243746

2013-09-19

Methods and materials for treatment of pompe's disease

#1571

20130230588

2013-09-05

CONTROLLED RELEASE COMPOSITIONS

#1572

20130224177

2013-08-29

Method of regulating fertilizing ability using cyclic ADP-ribose and CD38

#1573

20130224172

2013-08-29

METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS

#1574

20130224171

2013-08-29

Agent for use in the case of fructose intolerance

#1575

20130216517

2013-08-22

Standardized bee venom preparation

#1576

20130209568

2013-08-15

Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides

#1577

20130202583

2013-08-08

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

#1578

20130195836

2013-08-01

Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof

#1579

20130195834

2013-08-01

Treatment of glycogen storage disease type II

#1580

20130195833

2013-08-01

Methods and compositions for the treatment of symptoms of prion diseases

#1581

20130189357

2013-07-25

Methods and delivery vehicles for providing throat relief

#1582

20130189242

2013-07-25

Methods for improving the tissue penetration of a drug by administering the drug together with a hyaluronidase protein

#1583

20130177549

2013-07-11

Treatment of synucleinopathies

#1584

20130171121

2013-07-04

Maturation of gastrointestinal tract

#1585

20130164365

2013-06-27

Formulations for treatment with glucosinolates

#1586

20130164276

2013-06-27

Method for treating neuropathic pain

#1587

20130164275

2013-06-27

METHOD FOR TREATING ACIDOSIS IN RUMINANTS

#1588

20130156776

2013-06-20

Compositions and methods for treating cancer and modulating stress granule formation

#1589

20130156750

2013-06-20

Compositions and Methods for Using Human YKL-40 to Treat Acute Lung Injury

#1590

20130156703

2013-06-20

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

#1591

20130136729

2013-05-30

COMPOSITIONS AND METHODS FOR TARGETING AND TREATING DISEASES AND INJURIES USING ADENO-ASSOCIATED VIRUS VECTORS

#1592

20130129708

2013-05-23

Self-renewal promoter for neural stem cells and method for using same

#1593

20130129697

2013-05-23

Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

#1594

20130115203

2013-05-09

Enzyme and prebiotic combinations for enhancing probiotic efficacy

#1595

20130101634

2013-04-25

COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL OVERGROWTH IN THE SMALL INTESTINES

#1596

20130095186

2013-04-18

TEMPERATURE-SENSITIVE CARRIER FOR CARRYING A PHYSIOLOGICALLY ACTIVE SUBSTANCE AND PREPARATION METHOD THEREOF

#1597

20130095092

2013-04-18

Recombinant human NaGlu protein and uses thereof

#1598

20130090374

2013-04-11

METHODS FOR THE TREATMENT OF TAY-SACHS DISEASE, SANDHOFF DISEASE, AND GM1-GANGLIOSIDOSIS

#1599

20130071394

2013-03-21

Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use

#1600

20130064809

2013-03-14

Antimicrobial composition and uses thereof

#1601

20130059009

2013-03-07

COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERS

#1602

20130059001

2013-03-07

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

#1603

20130058978

2013-03-07

INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLS

#1604

20130058977

2013-03-07

COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPES

#1605

20130058976

2013-03-07

ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPY

#1606

20130058975

2013-03-07

ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSES

#1607

20130058974

2013-03-07

ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES

#1608

20130058970

2013-03-07

INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINES

#1609

20130058963

2013-03-07

INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLS

#1610

20130058912

2013-03-07

Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections

#1611

20130058902

2013-03-07

DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODS

#1612

20130058901

2013-03-07

TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE

#1613

20130058894

2013-03-07

THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE

#1614

20130058893

2013-03-07

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

#1615

20130052183

2013-02-28

METHODS FOR THE TREATMENT OF MORGELLONS DISEASE

#1616

20130052182

2013-02-28

Method of reducing biofilms

#1617

20130039901

2013-02-14

Treatment of Pompe's Disease

#1618

20130035290

2013-02-07

Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury

#1619

20130028882

2013-01-31

ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE

#1620

20130028874

2013-01-31

METHODS, PHARMACEUTICAL COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR ADMINISTERING THERAPEUTIC CELLS TO THE ANIMAL CENTRAL NERVOUS SYSTEM

#1621

20130028856

2013-01-31

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

#1622

20130022592

2013-01-24

Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme

#1623

20130022588

2013-01-24

Stable formulations of a hyaluronan-degrading enzyme

#1624

20130022576

2013-01-24

Compositions and methods for reducing the incidence of equine digestive disorders

#1625

20130017211

2013-01-17

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#1626

20130011410

2013-01-10

Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule

#1627

20130011378

2013-01-10

Stable formulations of a hyaluronan-degrading enzyme

#1628

20130005818

2013-01-03

Glycogen or polysaccharide storage disease treatment method

#1629

20130004565

2013-01-03

Proteolytic enzyme formulations

#1630

20120321605

2012-12-20

Artificial saliva comprising hyaluronic acid

#1631

20120315260

2012-12-13

Compositions and Methods to Prevent and Treat Biofilms

#1632

20120308549

2012-12-06

Process for production and purification of recombinant lysosomal alpha-mannosidase

#1633

20120308543

2012-12-06

Lipase variants for pharmaceutical use

#1634

20120308541

2012-12-06

PHARMACEUTICAL COMPOSITION FOR TREATING THE GASTROINTESTINAL TRACT

#1635

20120308524

2012-12-06

COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY

#1636

20120301460

2012-11-29

Subcutaneously administered anti-IL-6 receptor antibody

#1637

20120295327

2012-11-22

Targeted therapeutic proteins

#1638

20120294831

2012-11-22

USE OF THIAZOLIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES, CANCER AND DISEASES CAUSED BY INTRACELLULAR INFECTIONS

#1639

20120294830

2012-11-22

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#1640

20120288537

2012-11-15

ACTIVE SELF-HEALING BIOMATERIAL SYSTEM

#1641

20120288489

2012-11-15

Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

#1642

20120282231

2012-11-08

Human lysosomal proteins from plant cell culture

#1643

20120258149

2012-10-11

Methods and compositions for the treatment of influenza

#1644

20120258089

2012-10-11

Soluble β-N-acetylglucosaminidase based antibiofilm compositions and uses thereof

#1645

20120258088

2012-10-11

Chimeric bacteriophage lysin with activity against bacteria

#1646

20120251620

2012-10-04

Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)

#1647

20120251517

2012-10-04

Super fast-acting insulin compositions

#1648

20120251516

2012-10-04

Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

#1649

20120251498

2012-10-04

Gene Delivery to Organs

#1650

20120237495

2012-09-20

Method of treatment using solubilized protein composition obtained from eggshell membrane

#1651

20120237476

2012-09-20

Pharmaceutical compositions for sustained release delivery of peptides

#1652

20120232021

2012-09-13

Peptide linkers for polypeptide compositions and methods for using same

#1653

20120230974

2012-09-13

ALKALINE ALPHA GALACTOSIDASE FOR THE TREATMENT OF FABRY DISEASE

#1654

20120230973

2012-09-13

LACTASE PREPARATION

#1655

20120230970

2012-09-13

Method for treating pervasive development disorders

#1656

20120230944

2012-09-13

Stabilization and storage of biological pharmaceutical compositions

#1657

20120220517

2012-08-30

Glycopegylation methods and proteins/peptides produced by the methods

#1658

20120219554

2012-08-30

EXTRACELLULAR YALURONIDASE FROM STREPTOMYCES KOGANEIENSIS

#1659

20120213890

2012-08-23

Spray dried myrosinase and use to produce isothiocynates

#1660

20120213762

2012-08-23

Lysosomal targeting peptides and uses thereof

#1661

20120207741

2012-08-16

Enzymes For Pharmaceutical Use

#1662

20120207740

2012-08-16

Method for treating pervasive development disorders

#1663

20120207726

2012-08-16

Autism-associated biomarkers and uses thereof

#1664

20120201780

2012-08-09

T. CRUZI-DERIVED NEUROTROPHIC AGENTS AND METHODS OF USE THEREFOR

#1665

20120195945

2012-08-02

Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly

#1666

20120190882

2012-07-26

Efficient isolation of cimiracemate A, and methods of use

#1667

20120189703

2012-07-26

Enzyme Delivery Systems and Methods of Preparation and Use

#1668

20120189608

2012-07-26

Endolysin OBPgpLYS

#1669

20120189607

2012-07-26

METHOD OF REGULATING FERTILIZING ABILITY USING CYCLIC ADP-RIBOSE AND CD38

#1670

20120189606

2012-07-26

Antimicrobial agents

#1671

20120189601

2012-07-26

Assisted enzyme replacement therapy

#1672

20120183502

2012-07-19

COMBINATION THERAPY FOR LYSOSOMAL STORAGE DISEASES

#1673

20120178699

2012-07-12

Klotho protein and related compounds for the treatment and diagnosis of cancer

#1674

20120177695

2012-07-12

Bioerodible silicon-based devices for delivery of therapeutic agents

#1675

20120171153

2012-07-05

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

#1676

20120156248

2012-06-21

Augmentation of titer for vaccination in animals

#1677

20120149760

2012-06-14

Disabling autophagy as a treatment for lysosomal storage diseases

#1678

20120148558

2012-06-14

Delivery of therapeutic compounds to the brain and other tissues

#1679

20120148556

2012-06-14

Formulations for lysosomal enzymes

#1680

20120148555

2012-06-14

Hyaluronidase and factor VIII compositions

#1681

20120142756

2012-06-07

mRNA for use in treatment of human genetic diseases

#1682

20120141590

2012-06-07

Technology for the Preparation of Microparticles

#1683

20120141507

2012-06-07

Targeting of glycoprotein therapeutics

#1684

20120141452

2012-06-07

Targeted therapeutic proteins

#1685

20120135468

2012-05-31

Beta-galactosidase derived from

#1686

20120121572

2012-05-17

Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity

#1687

20120116062

2012-05-10

Technology for preparation of macromolecular microspheres

#1688

20120114627

2012-05-10

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

#1689

20120114626

2012-05-10

Method for treating pervasive development disorders

#1690

20120114562

2012-05-10

Method for treating pervasive development disorders

#1691

20120109106

2012-05-03

DRUG DELIVERY SYSTEM FOR ACCELERATED SUBCUTANEOUS ABSORPTION

#1692

20120107243

2012-05-03

PEPTIDE-MEDIATED NON-COVALENT DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER

#1693

20120100149

2012-04-26

Injectable, non-aqueous suspension with high concentration of therapeutic agent

#1694

20120100125

2012-04-26

LOCAL DEHYDRATION FOR CARPAL TUNNEL SYNDROME

#1695

20120093770

2012-04-19

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#1696

20120082653

2012-04-05

Methods of lysosomal storage disease therapy

#1697

20120076767

2012-03-29

Process for concentration of a polypeptide

#1698

20120076730

2012-03-29

Peptides for transport of therapeutics and their carriers in mouse models and humans

#1699

20120070504

2012-03-22

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

#1700

20120070441

2012-03-22

EXTRACELLULAR YALURONIDASE FROM STREPTOMYCES KOGANEIENSIS

#1701

20120070423

2012-03-22

ORAL COMPOSITION AND METHOD OF FORMING AND USING SAME

#1702

20120058132

2012-03-08

Treatment of glycogen storage disease type II

#1703

20120052053

2012-03-01

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION

#1704

20120040432

2012-02-16

Methods for making polymeric nanoparticle-polypeptide complex

#1705

20120039985

2012-02-16

Dendritic cell modulation in post-ischemic wounds

#1706

20120034200

2012-02-09

Formulations including digestive enzymes, polysorbate-based surfactants and probiotics

#1707

20120027848

2012-02-02

Enzyme delivery systems and methods of preparation and use

#1708

20120021490

2012-01-26

GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM

#1709

20120021487

2012-01-26

Method of treating gaucher disease

#1710

20120020951

2012-01-26

Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

#1711

20120020947

2012-01-26

COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE

#1712

20120014921

2012-01-19

Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

#1713

20120003715

2012-01-05

Process for Producing Recombinant Lyosomal Using Insect Larvae

#1714

20120003202

2012-01-05

CNS delivery of therapeutic agents

#1715

20110318324

2011-12-29

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASE

#1716

20110312058

2011-12-22

Polypeptides with xylanase activity

#1717

20110294193

2011-12-01

VIRAL VECTORS AND METHODS FOR PRODUCING AND USING THE SAME

#1718

20110286993

2011-11-24

Use of Hsp70 as a regulator of enzymatic activity

#1719

20110286986

2011-11-24

Lactoferrin and angiogenin compositions and uses thereof

#1720

20110286937

2011-11-24

SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME

#1721

20110280854

2011-11-17

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

#1722

20110280853

2011-11-17

Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces

#1723

20110268721

2011-11-03

Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease

#1724

20110262961

2011-10-27

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

#1725

20110262413

2011-10-27

Methods of reducing extravasation of inflammatory cells

#1726

20110256116

2011-10-20

Low/high dose probiotic supplements and methods of their use

#1727

20110250251

2011-10-13

Cosmetic Methods And Compositions For Repairing Human Skin

#1728

20110250181

2011-10-13

Human lysosomal proteins from plant cell culture

#1729

20110245149

2011-10-06

Methods to prevent and treat diseases

#1730

20110243901

2011-10-06

Cell therapy for the treatment of lysosomal storage disorders

#1731

20110229452

2011-09-22

Ophthalmic Surgical Irrigating Solutions Containing Hyaluronidase

#1732

20110223233

2011-09-15

Microfabricated nanopore device for sustained release of therapeutic agent

#1733

20110223147

2011-09-15

LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF

#1734

20110212074

2011-09-01

Myeloid colony stimulating factor and uses thereof

#1735

20110200575

2011-08-18

Metallo-lactoferrin-coenzyme compositions to improve sleep patterns

#1736

20110196319

2011-08-11

Composition and system for wound decontamination

#1737

20110189157

2011-08-04

USE OF HUMAN HYALURONIDASES FOR AXONAL REGROWTH

#1738

20110182986

2011-07-28

CONTROLLED RELEASE COMPOSITION

#1739

20110182875

2011-07-28

Class of therapeutic protein based molecules

#1740

20110182874

2011-07-28

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#1741

20110182873

2011-07-28

Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#1742

20110182868

2011-07-28

Human lysosomal proteins from plant cell culture

#1743

20110182818

2011-07-28

Methods and compositions for the treatment of symptoms of neurological and mental health disorders

#1744

20110177195

2011-07-21

ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS

#1745

20110177111

2011-07-21

Protective vaccine against biofilms comprising cell wall-associated immunogens

#1746

20110177050

2011-07-21

Methods comprising serratia peptidase for inhibition of osteomyelitis

#1747

20110177049

2011-07-21

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#1748

20110177048

2011-07-21

Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis

#1749

20110171345

2011-07-14

Enzymes for reduced immunological stress

#1750

20110171344

2011-07-14

ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS

#1751

20110171189

2011-07-14

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

#1752

20110171132

2011-07-14

Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract

#1753

20110165149

2011-07-07

Targeting ABCB5 for cancer therapy

#1754

20110158976

2011-06-30

Enzymes for pharmaceutical use

#1755

20110152359

2011-06-23

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

#1756

20110150853

2011-06-23

MYCOTOXIN-REDUCING COMPOSITION

#1757

20110142818

2011-06-16

Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases

#1758

20110135728

2011-06-09

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF POLYPEPTIDES

#1759

20110135626

2011-06-09

Localized Chemical Lysis of Ocular Tissue

#1760

20110135624

2011-06-09

THERAPEUTIC COMPOSITION FOR AUTOIMMUNE CONDITIONS

#1761

20110129454

2011-06-02

Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#1762

20110123634

2011-05-26

Stable digestive enzyme compositions

#1763

20110123633

2011-05-26

Stable digestive enzyme compositions

#1764

20110123625

2011-05-26

Compositions of Less Immunogenic and Long-Circulating Protein-Lipid Complexes

#1765

20110123605

2011-05-26

Stable digestive enzyme compositions

#1766

20110123591

2011-05-26

TUMORICIDAL, BACTERICIDAL, OR VIRICIDAL MACROPHAGE ACTIVATION

#1767

20110110919

2011-05-12

Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan

#1768

20110110905

2011-05-12

Infant Colic Supplement

#1769

20110104187

2011-05-05

Method of treating glycogen storage disease type III with human acid α-glucosidase

#1770

20110104140

2011-05-05

USE OF NON-CATALYTIC FORM OF HEPARANASE AND PEPTIDES THEREOF FOR REVERSING THE ANTI-COAGULANT EFFECTS OF HEPARINOIDS

#1771

20110097329

2011-04-28

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

#1772

20110091442

2011-04-21

Compositions for preventing and/or treating lysosomal storage disorders

#1773

20110091414

2011-04-21

Stabilized compositions of proteins having a free thiol moeity

#1774

20110086101

2011-04-14

DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof

#1775

20110076273

2011-03-31

Highly Concentrated Pharmaceutical Formulations

#1776

20110065189

2011-03-17

Lacritin-Syndecan Interactions

#1777

20110064720

2011-03-17

Dietary Supplement Compositions and Methods of Making and Using the Same

#1778

20110064712

2011-03-17

Dietary Supplement Compositions and Methods of Making and Using the Same

#1779

20110059508

2011-03-10

IMPROVING AGENT FOR DYSFUNCTION DUE TO NEUROPATHY AND RHO KINASE ACTIVATION INHIBITOR

#1780

20110059172

2011-03-10

THERAPEUTIC COMPOSITIONS

#1781

20110059062

2011-03-10

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN AIRWAY PASSAGES

#1782

20110052706

2011-03-03

Pancreatine pellets and method of producing same

#1783

20110044977

2011-02-24

Subcutaneous anti-HER2 antibody formulations and uses thereof

#1784

20110044969

2011-02-24

Antimicrobial Agents for the Treatment of Campylobacter Species in the Crop of a Bird

#1785

20110044966

2011-02-24

Use of a substance for manufacturing of a medicament for treatment of common cold

#1786

20110038851

2011-02-17

Treatment of synucleinopathies

#1787

20110034401

2011-02-10

Process for solubilizing protein from a proteinaceous material and compositions thereof

#1788

20110033440

2011-02-10

Solubilized protein composition obtained from avian eggshell membrane

#1789

20110027255

2011-02-03

Composition and method for treating papilloma virus and equine sarcoids

#1790

20110027254

2011-02-03

COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE

#1791

20110027241

2011-02-03

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells

#1792

20110027237

2011-02-03

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells

#1793

20110020282

2011-01-27

RECOMBINANT NEWCASTLE DISEASE VIRUS

#1794

20110014178

2011-01-20

Antimicrobial Composition and Method for Use

#1795

20110008309

2011-01-13

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#1796

20110002912

2011-01-06

COMPOSITION

#1797

20110002909

2011-01-06

METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN

#1798

20110002908

2011-01-06

Treatment of α-galactosidase A deficiency

#1799

20100329995

2010-12-30

COMPOSITIONS CONTAINING LACTOFERRIN, AND METHODS OF USING SAME TO PROMOTE GROWTH OF SKIN CELLS

#1800

20100322915

2010-12-23

Protease variants for pharmaceutical use